516 related articles for article (PubMed ID: 21325441)
1. Reducing the late sodium current improves cardiac function during sodium pump inhibition by ouabain.
Hoyer K; Song Y; Wang D; Phan D; Balschi J; Ingwall JS; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2011 May; 337(2):513-23. PubMed ID: 21325441
[TBL] [Abstract][Full Text] [Related]
2. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
[TBL] [Abstract][Full Text] [Related]
3. The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.
Wu Y; Song Y; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2009 Aug; 330(2):550-7. PubMed ID: 19403851
[TBL] [Abstract][Full Text] [Related]
4. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction.
Song Y; Shryock JC; Wagner S; Maier LS; Belardinelli L
J Pharmacol Exp Ther; 2006 Jul; 318(1):214-22. PubMed ID: 16565163
[TBL] [Abstract][Full Text] [Related]
5. Late sodium current inhibition alone with ranolazine is sufficient to reduce ischemia- and cardiac glycoside-induced calcium overload and contractile dysfunction mediated by reverse-mode sodium/calcium exchange.
Soliman D; Wang L; Hamming KS; Yang W; Fatehi M; Carter CC; Clanachan AS; Light PE
J Pharmacol Exp Ther; 2012 Nov; 343(2):325-32. PubMed ID: 22879384
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of cardiac actions of ouabain and its binding to Na+, K+-adenosine triphosphatase by increased sodium influx in isolated guinea-pig heart.
Temma K; Akera T
J Pharmacol Exp Ther; 1982 Nov; 223(2):490-6. PubMed ID: 6290640
[TBL] [Abstract][Full Text] [Related]
7. Longer term effects of ouabain on the contractility of rat isolated cardiomyocytes and on the expression of Ca and Na regulating proteins.
Müller-Ehmsen J; Nickel J; Zobel C; Hirsch I; Bölck B; Brixius K; Schwinger RH
Basic Res Cardiol; 2003 Mar; 98(2):90-6. PubMed ID: 12607130
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of intracellular sodium from contractile state in guinea-pig hearts treated with ouabain.
Radford NB; Makos JD; Ramasamy R; Sherry AD; Malloy CR
J Mol Cell Cardiol; 1998 Mar; 30(3):639-47. PubMed ID: 9515039
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Na+, K+-adenosine triphosphatase inhibition by ouabain and myocardial sodium: a computer simulation.
Akera T; Bennett RT; Olgaard MK; Brody TM
J Pharmacol Exp Ther; 1976 Nov; 199(2):287-97. PubMed ID: 135837
[TBL] [Abstract][Full Text] [Related]
10. Cardiac glycosides: relationship among active 86Rb uptake, (Na+,K+)-ATPase activity, and inotropy in guinea pig heart.
Akera T; Ku D; Brody TM
Recent Adv Stud Cardiac Struct Metab; 1976; 9():337-44. PubMed ID: 130662
[TBL] [Abstract][Full Text] [Related]
11. Early reperfusion levels of Na(+) and Ca(2+) are strongly associated with postischemic functional recovery but are disassociated from K(ATP) channel-induced cardioprotection.
Takayama E; Guo LL; Digerness SB; Pike MM
J Mol Cell Cardiol; 2004 Aug; 37(2):483-96. PubMed ID: 15276018
[TBL] [Abstract][Full Text] [Related]
12. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
Belardinelli L; Liu G; Smith-Maxwell C; Wang WQ; El-Bizri N; Hirakawa R; Karpinski S; Li CH; Hu L; Li XJ; Crumb W; Wu L; Koltun D; Zablocki J; Yao L; Dhalla AK; Rajamani S; Shryock JC
J Pharmacol Exp Ther; 2013 Jan; 344(1):23-32. PubMed ID: 23010360
[TBL] [Abstract][Full Text] [Related]
13. Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium.
Sossalla S; Kallmeyer B; Wagner S; Mazur M; Maurer U; Toischer K; Schmitto JD; Seipelt R; Schöndube FA; Hasenfuss G; Belardinelli L; Maier LS
J Am Coll Cardiol; 2010 May; 55(21):2330-42. PubMed ID: 20488304
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Na+-K+ pump and L-type Ca2+ channel by glibenclamide in Guinea pig ventricular myocytes.
Lee SY; Lee CO
J Pharmacol Exp Ther; 2005 Jan; 312(1):61-8. PubMed ID: 15365090
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of Na/K-ATPase alpha-subunit isoform gene expressions in cardiac myocytes by ouabain and other hypertrophic stimuli.
Huang L; Kometiani P; Xie Z
J Mol Cell Cardiol; 1997 Nov; 29(11):3157-67. PubMed ID: 9405189
[TBL] [Abstract][Full Text] [Related]
16. Na+/K+-ATPase inhibition by ouabain induces CaMKII-dependent apoptosis in adult rat cardiac myocytes.
Sapia L; Palomeque J; Mattiazzi A; Petroff MV
J Mol Cell Cardiol; 2010 Sep; 49(3):459-68. PubMed ID: 20435043
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of normothermic reperfusion with oxygenated potassium cardioplegia: a possible mechanism.
Yamamoto H; Magishi K; Goh K; Sasajima T; Yamamoto F
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):598-604. PubMed ID: 19584068
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine inhibits an oxidative stress-induced increase in myocyte sodium and calcium loading during simulated-demand ischemia.
Zhang XQ; Yamada S; Barry WH
J Cardiovasc Pharmacol; 2008 May; 51(5):443-9. PubMed ID: 18398379
[TBL] [Abstract][Full Text] [Related]
19. Effects of progesterone derivatives on sodium pump activity and force of myocardial contraction in isolated guinea pig heart.
Temma K; Ng YC; Brody TM; Akera T
Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):51-63. PubMed ID: 6194547
[TBL] [Abstract][Full Text] [Related]
20. Ischemia-induced enhancement of digitalis sensitivity in isolated guinea-pig heart.
Kim DH; Akera T; Kennedy RH
J Pharmacol Exp Ther; 1983 Aug; 226(2):335-42. PubMed ID: 6308206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
